Medical Treatments

As California's attorney general, Xavier Becerra fought Trump-era restrictions on reproductive health. If confirmed, he'll navigate an even more difficult legal and political landscape.

Sepsis is one of the most common causes of death for hospitalized patients. The search for an effective treatment has been frustrating.

The U.S. is engaged in a massive effort to vaccinate the bulk of its population against COVID-19. But some states are working faster than others. See how yours is faring.

Dr. Rochelle Walensky says scientists at the Centers for Disease Control and Prevention were "muzzled" and "diminished" by the Trump team, especially during the pandemic. She aims to fix that.

The Biden team wants to swiftly vaccinate people of color and others most vulnerable to COVID-19. But health centers are learning that speed and achieving racial equity don't always go hand in hand.

A seemingly easy and cheap treatment for a deadly disease has failed in a major study. Vitamin C is apparently not useful for sepsis after all. That's a lesson for similar COIVD-19 treatments.

As the country faces another wrenching milestone, there are signs of hope that we may be beating back the virus. But a brighter future won't bring back precious lives lost.

In Washington, D.C., hospital staff vaccinated 1,750 public school workers in one day. It was a hard-won success amid a fragmented nationwide vaccination campaign fraught with challenges.

Researchers are trying to learn more about COVID-19 vaccines from original study participants. The quest is hampered because many people who first received a placebo shot are opting for the vaccine.

Power outages and snowstorms have suspended mass vaccination clinics in Missouri and Texas. Vaccine managers are working to reschedule appointments and to limit the impact of disruptions.

Use NPR's tool to find out where to start when it's your turn to get the COVID-19 vaccine. Plus, helpful advice about how to navigate the system.

Scientists are trying to learn more about COVID-19 vaccines from original study participants. That quest is hampered because many people who received a placebo shot have now opted to get the vaccine.